Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ren-Jye LinYi-Ling Lin

Abstract

The 2',5'-oligoadenylate synthetase (OAS) and its downstream effector RNase L play important roles in host defense against virus infection. Oas1b, one of the eight Oas1 genes in the mouse genome, has been identified as a murine flavivirus-resistance gene. Four genes, OAS1, OAS2, OAS3, and OAS-like (OASL), have been identified in the human OAS gene family, and 10 isoforms, including OAS1 (p42, p44, p46, p48, and p52), OAS2 (p69 and p71), OAS3 (p100), and OASL (p30 and p59) can be generated by alternative splicing. In this study, we determined the role of the human OAS/RNase L pathway in host defense against dengue virus (DEN) infection and assessed the antiviral potential of each isoform in the human OAS family. DEN replication was reduced by overexpression and enhanced by knockdown of RNase L expression, indicating a protective role for RNase L against DEN replication in human cells. The human OAS1 p42, OAS1 p46, and OAS3 p100, but not the other OAS isoforms, blocked DEN replication via an RNase L-dependent mechanism. Furthermore, the anti-DEN activities of these three OAS isoforms correlated with their ability to trigger RNase L activation in DEN-infected cells. Thus, OAS1 p42/p46 and OAS3 p100 are likely to contribute to host...Continue Reading

References

Feb 24, 1995·The Journal of Biological Chemistry·B Dong, R H Silverman
Dec 16, 1998·Journal of Virology·A J Johnson, J T Roehrig
May 20, 1999·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D Rebouillat, A G Hovanessian
Dec 23, 1999·The Journal of Infectious Diseases·D W VaughnA Nisalak
Oct 5, 2001·Clinical Microbiology Reviews·C E Samuel
May 10, 2002·The Journal of Infectious Diseases·Daniel H LibratyAlan L Rothman
Jun 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Andrey A PerelyginMargo A Brinton
Aug 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tomoji MashimoPhilippe Despres
Oct 23, 2003·The Journal of Biological Chemistry·Geqiang LiRobert H Silverman
Dec 24, 2005·The Journal of Biological Chemistry·Anna Kajaste-RudnitskiPhilippe Desprès
Feb 2, 2006·BMC Molecular Biology·Andreas SchroederThomas Ragg
Feb 28, 2006·Journal of Virology·Svetlana V ScherbikMargo A Brinton
Jul 27, 2007·Nature·Krishnamurthy MalathiRobert H Silverman
Dec 7, 2007·PLoS Neglected Tropical Diseases·Joshua FinkMartin L Hibberd
Jan 6, 2009·Microbes and Infection·Lark L CoffeyAnavaj Sakuntabhai

❮ Previous
Next ❯

Citations

Dec 15, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Helle KristiansenRune Hartmann
Sep 22, 2011·PloS One·Abigail W BighamMichael Bamshad
Jun 23, 2011·PLoS Pathogens·Jazmina L G CruzSonia Zuñiga
Feb 13, 2014·Viruses·Manoj N Krishnan, Mariano A Garcia-Blanco
Sep 11, 2014·BMC Cell Biology·Karina Hansen KjærPia Møller Martensen
Mar 17, 2015·Proceedings of the National Academy of Sciences of the United States of America·Jesse DonovanAlexei Korennykh
Feb 10, 2016·Proceedings of the National Academy of Sciences of the United States of America·Yize LiSusan R Weiss
Jun 13, 2015·The Journal of Infectious Diseases·Etienne Simon-LoriereAnavaj Sakuntabhai
Sep 18, 2014·The Journal of General Virology·Wei ZhangPo Tien
Sep 29, 2015·Virology Journal·Helen K Palma-OcampoGerardo Santos-López
Aug 8, 2014·The Biochemical Journal·Katell Bidet, Mariano A Garcia-Blanco
Jul 6, 2014·Frontiers in Microbiology·Sankar Bhattacharyya
Oct 17, 2016·Rheumatology·Fabio E OspinaGabriel J Tobón
Aug 25, 2016·Scientific Reports·Chin-Kai TsengJin-Ching Lee
Jan 19, 2018·Annual Review of Immunology·Annie Elong Ngono, Sujan Shresta
Mar 7, 2015·Experimental & Molecular Medicine·Un Yung ChoiYoung-Joon Kim
Sep 7, 2017·The Journal of General Virology·Wei ZhangAnchun Cheng
Sep 1, 2016·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Chao YangAnchun Cheng
Feb 2, 2012·The Journal of Toxicological Sciences·Masayuki UeharaKiyoshi Matsumoto
May 31, 2019·Journal of Virology·Jillian N WhelanSusan R Weiss
Jul 18, 2014·Endocrine Journal·Atsushi YoshikawaIichiro Shimomura
Feb 6, 2020·Viruses·Han DiMargo A Brinton

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Bowen's Disease

Bowen's disease is thought of as an easily-treatable early stage of skin cancer, characterized by red, scaly patches on the skin. Discover the latest research on Bowen's disease here.

Anal Dysplasia

Anal dysplasia is a precancerous condition in which some cells within the anus transform into abnormal cells. Discover the latest research on anal dysplasia here.

Related Papers

Cellular and Molecular Life Sciences : CMLS
Signe EskildsenJ Justesen
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Shigeru KakutaYoichiro Iwakura
© 2022 Meta ULC. All rights reserved